SEC Comment Letter 0000000000-23-008678 to iBio, Inc. (IBIO)
iBio, Inc.
Date: Aug. 9, 2023 · CIK: 0001420720 · Accession: 0000000000-23-008678
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-273749
Letter
United States securities and exchange commission logo August 9, 2023 Martin Brenner, Ph.D. Chief Executive Officer iBio, Inc. 8800 HSC Parkway Bryan, TX 77807 Re:iBio, Inc. Registration Statement on Form S-1 Filed August 7, 2023 File No. 333-273749 Dear Martin Brenner: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tyler Howes at 202-551-3370 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Leslie Marlow, Esq.
Show Raw Text
United States securities and exchange commission logo
August 9, 2023
Martin Brenner, Ph.D.
Chief Executive Officer
iBio, Inc.
8800 HSC Parkway
Bryan, TX 77807
Re:iBio, Inc.
Registration Statement on Form S-1
Filed August 7, 2023
File No. 333-273749
Dear Martin Brenner:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tyler Howes at 202-551-3370 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Leslie Marlow, Esq.